Gene · 9656
Papers2,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 53BP1: Keeping It under Control, Even at a Distance from DNA Damage. | Genes (Basel) | 2022 | 36553657 | PubTator, text mining | PubMed |
| TRIP13 Participates in Immediate-Early Sensing of DNA Strand Breaks and ATM Signaling Amplification through MRE11. | Cells | 2022 | 36552858 | PubTator, text mining | PubMed |
| Divergent Molecular and Cellular Responses to Low and High-Dose Ionizing Radiation. | Cells | 2022 | 36497055 | PubTator, text mining | PubMed |
| TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma. | BMC Cancer | 2022 | 36434554 | PubTator, text mining | PubMed |
| Synthesis, Self-Assembly in Crystalline Phase and Anti-Tumor Activity of 2-(2-/4-Hydroxybenzylidene)thiazolo[3,2-a]pyrimidines. | Molecules | 2022 | 36431842 | PubTator, text mining | PubMed |
| Fusion gene recurrence in non-small cell lung cancers and its association with cigarette smoke exposure. | Transl Lung Cancer Res | 2022 | 36386463 | PubTator, text mining | PubMed |
| The equilibrium of tumor suppression: DUBs as active regulators of PTEN. | Exp Mol Med | 2022 | 36385557 | PubTator, text mining | PubMed |
| Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial. | Cell Rep Med | 2022 | 36384100 | PubTator, text mining | PubMed |
| Early recruitment of PARP-dependent m8A RNA methylation at DNA lesions is subsequently accompanied by active DNA demethylation. | RNA Biol | 2022 | 36382943 | PubTator, text mining | PubMed |
| Replication stress defines distinct molecular subtypes across cancers. | Cancer Res Commun | 2022 | 36381660 | PubTator, text mining | PubMed |
| Post-Translational Modifications by Lipid Metabolites during the DNA Damage Response and Their Role in Cancer. | Biomolecules | 2022 | 36359005 | PubTator, text mining | PubMed |
| Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations. | Biomolecules | 2022 | 36358986 | PubTator, text mining | PubMed |
| The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset. | Curr Issues Mol Biol | 2022 | 36354684 | PubTator, text mining | PubMed |
| PARP1 proximity proteomics reveals interaction partners at stressed replication forks. | Nucleic Acids Res | 2022 | 36350633 | PubTator, text mining | PubMed |
| Processes in DNA damage response from a whole-cell multi-omics perspective. | iScience | 2022 | 36339253 | PubTator, text mining | PubMed |
| Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36338767 | PubTator, text mining | PubMed |
| TP53 Mutation Mapping in Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Cohort Study. | Curr Oncol | 2022 | 36290859 | PubTator, text mining | PubMed |
| Meta-analysis of active tuberculosis gene expression ascertains host directed drug targets. | Front Cell Infect Microbiol | 2022 | 36275035 | PubTator, text mining | PubMed |
| Role of fibroblasts in wound healing and tissue remodeling on Earth and in space. | Front Bioeng Biotechnol | 2022 | 36267456 | PubTator, text mining | PubMed |
| RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer. | Adv Drug Deliv Rev | 2022 | 36252617 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9656/papers?page=16